News

A strong desire to travel has contributed to an increase in COVID-19 vaccination rates, which could aid the travel industry's economic recovery.

UC Riverside-led study shows how an effective therapy against SARS-CoV-2 could be developed.

Macrophages that have been grown in cell culture have been shown to function normally when returned to the body, suggesting macrophages are a promising avenue for living therapeutics.

Tufts researchers are building a reputation for precision targeting in drug delivery. Their tools: tiny lipid-based nanoparticles (LNPs) fine-tuned to latch on to specific tissues, organs, even cell types within the body. Their latest creation: LNPs that carry genetic instructions directly into the lungs.

Chemists at MIT have developed a novel way to synthesize himastatin, a natural compound that has shown potential as an antibiotic.

A nanoparticle-based vaccine could help mitigate the damage of one of the most devastating illnesses in swine farming.

A new study shows how certain RNA molecules control the repair of damaged DNA in cancer cells, a discovery that could eventually give rise to better cancer treatments.

A key transcription factor in T-cell immunology is crucial to the immune system’s “memory”. It may be possible to improve this immunological memory in vaccines, according to a new paper by scientists at the Hackensack Meridian Center for Discovery and Innovation (CDI).

Gene therapy that uses modified stem cells from the patient has been used to treat thalassemia, an inherited blood disorder. The majority of patients that received the gene therapy no longer need monthly blood transfusions.

A study has reviewed dozens of evaluations of four COVID-19 vaccines and found that they retain nearly all of their ability to prevent severe disease up to six months after full vaccination.